Holen Sie sich die Stockscreener-App
35.34
0.97%
0.34
Schlusskurs vom Vortag:
$35.00
Offen:
$35.19
24-Stunden-Volumen:
35,957
Relative Volume:
0.25
Marktkapitalisierung:
$558.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-2.614
EPS:
-13.5194
Netto-Cashflow:
$22.49M
1W Leistung:
-4.97%
1M Leistung:
+12.44%
6M Leistung:
+121.01%
1J Leistung:
+116.68%
1-Tages-Spanne:
$34.52
$35.82
1-Wochen-Bereich:
$33.28
$39.47
52-Wochen-Spanne:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
35.34 | 553.60M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Why ETFs are accumulating Assembly Biosciences Inc. (V7B) stockGap Up & High Yield Stock Recommendations - Newser
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) Shift From Loss To Profit - Yahoo Finance
Why Assembly Biosciences Inc. (V7B) stock is a strong analyst pick - Newser
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 8.3%Time to Sell? - MarketBeat
Responsive Playbooks and the ASMB Inflection - news.stocktradersdaily.com
Can Assembly Biosciences Inc. (V7B) stock test all time highsJuly 2025 Momentum & Safe Capital Growth Trade Ideas - Newser
Will Assembly Biosciences Inc. (V7B) stock see insider accumulationEarnings Recap Summary & AI Enhanced Trading Alerts - Newser
Financial Comparison: Assembly Biosciences (NASDAQ:ASMB) versus Evoke Pharma (NASDAQ:EVOK) - Defense World
Analyzing Evoke Pharma (NASDAQ:EVOK) & Assembly Biosciences (NASDAQ:ASMB) - Defense World
H.C. Wainwright Reaffirms Buy Rating on Assembly Biosciences, Inc. (ASMB) Amid Promising Trial Data - MSN
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Assembly Biosciences (ASMB) - The Globe and Mail
Understanding the Setup: (ASMB) and Scalable Risk - news.stocktradersdaily.com
Will Assembly Biosciences Inc. stock outperform international peersWeekly Market Outlook & Smart Investment Allocation Tips - newser.com
What analysts say about Assembly Biosciences Inc stockCurrency Fluctuation Impact & Double Or Triple Investment - earlytimes.in
Mizuho Maintains Assembly Biosciences (ASMB) Outperform Recommendation - Nasdaq
Assembly Biosciences (ASMB) Sees Raised Price Target From Mizuho - GuruFocus
Assembly Biosciences price target raised to $40 from $29 at Mizuho - TipRanks
Mizuho Raises Price Target on Assembly Biosciences to $40 From $29, Keeps Outperform Rating - marketscreener.com
How buyback programs support Assembly Biosciences Inc. (V7B) stockEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
How Assembly Biosciences Inc. (V7B) stock benefits from digital adoption2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
What drives Assembly Biosciences Inc V7B stock priceEarnings Per Share Trends & Fast Profit Investment Ideas - earlytimes.in
What to do if you’re stuck in Assembly Biosciences Inc.2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Will Assembly Biosciences Inc. (V7B) stock benefit from Fed rate cuts2025 Price Targets & Weekly High Momentum Picks - newser.com
Is Assembly Biosciences Inc. (V7B) stock a buy during volatile marketsInsider Selling & Real-Time Stock Movement Alerts - newser.com
Is Assembly Biosciences Inc. stock a buy before product launches2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Assembly Biosciences Inc. stock momentum explainedWeekly Trade Recap & High Return Trade Guides - newser.com
Will a bounce in Assembly Biosciences Inc. offer an exitWeekly Market Report & Risk Controlled Swing Alerts - newser.com
Statistical indicators supporting Assembly Biosciences Inc.’s strengthAnalyst Downgrade & Free Reliable Trade Execution Plans - newser.com
Evaluating Assembly Biosciences Inc. with trendline analysis2025 Retail Activity & Stepwise Trade Signal Implementation - newser.com
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):